Biologic agents used to treat rheumatoid arthritis and their relevance to podiatrists: a practice update

Simon Otter, J.R. Cyer

Research output: Contribution to journalArticle

Abstract

This review considers the pharmacological management of rheumatoid arthritis including the role of anti-tumour necrosis factor alpha (TNF) agents, as a precursor to highlighting some of the issues for podiatrists involved in the care of patients on this particular medication.
Original languageEnglish
Pages (from-to)51-59
Number of pages9
JournalMusculoskeletal Care
Volume2
Issue number1
DOIs
Publication statusPublished - Mar 2004

    Fingerprint

Keywords

  • Podiatry
  • rheumatoid arthritis
  • anti-TNF therapy

Cite this